The Historical Evolution of Patent Rights: From Monopoly Privileges to Modern Intellectual Property

Patents today are so ingrained in how we think about innovation that it’s easy to assume they’ve always existed in their current form – a legal right granted to inventors in exchange for disclosing their creations to the public. But this wasn’t always the case. For much of history, a “patent” was simply a royal favour – a tool wielded by monarchs to reward loyalists, fill treasury coffers, and control entire markets. The journey from those arbitrary Crown grants to the structured, innovation-focused patent systems we have today spans centuries, legal battles, and political upheavals. Understanding this evolution is essential for anyone studying intellectual property rights, particularly in the Indian context.

What does “patent” actually mean? 🔗

The word “patent” comes from the Latin littera patens, meaning “open letter.” Letters patent were public orders issued by the monarch, visible to all, used to grant titles, appoint officials, incorporate guilds, and – crucially – award exclusive trading or manufacturing rights to favoured individuals. The “openness” referred to the public nature of the grant, not any notion of fairness or access. It was essentially a royal command backed by sovereign authority.

The earliest roots: Venice and the first patent statute 🔗

Before England enters the picture, credit must be given to the Republic of Venice, which passed what historians widely regard as the world’s first formal patent statute in 1474. The Venetian Senate offered exclusive rights to inventors of new devices in exchange for disclosure to the Republic. The initiative was deliberately designed to revive a declining economy by attracting skilled craftsmen and encouraging new industries – a goal recognisably similar to what modern patent law aims to achieve.

In England, the earliest recorded patent for invention was granted in 1449 by King Henry VI to John of Utynam, a Flemish stained glass maker, who received a 20-year monopoly for a glass-making process unknown in England at the time. This began the Tudor tradition of issuing letters patent for new trades and industries.

Crown monopolies and the abuse of royal privilege 🔗

By the time of Queen Elizabeth I, the grant of patents had mutated far beyond rewarding genuine inventions. The Crown used patents extensively to issue monopolies over common everyday commodities like starch and salt – essentially taxing the public without calling it a tax. Powerful courtiers received exclusive rights over goods they had nothing to do with inventing. These became known as “odious monopolies,” and public resentment grew rapidly.

Elizabeth I did make a partial concession in 1601 under parliamentary pressure, promising to let patent cases be heard in common law courts. But her successor, James I continued issuing sweeping monopoly grants even after acknowledging Elizabethan excesses, essentially promising reform with one hand while expanding abuses with the other. Parliament, increasingly assertive, was running out of patience.

The Statute of Monopolies, 1624: a turning point in legal history 🔗

The defining moment in the history of patent law came on 29 May 1624, when the English Parliament passed the Statute of Monopolies, largely driven by the efforts of jurist Sir Edward Coke. The statute declared virtually all existing monopolies void. But critically, it preserved one important exception under Section 6: patents could still be granted to the “true and first inventor” of a new “manner of manufacture” – but for no longer than 14 years.

This was a watershed shift. For the first time, a patent was not a royal favour – it was a legal entitlement tied to genuine novelty and inventorship. The statute also introduced the concept of time-limited protection, acknowledging that a monopoly should serve the public eventually by expiring. The Statute of Monopolies was intended to curtail royal abuse of monopoly privileges, and its influence was profound – it shaped not just English patent law but also influenced the drafting of the United States Patent and Copyright Clause in 1787, and its framework was received into patent law across many common law jurisdictions.

What Section 6 actually said 🔗

Section 6 of the Statute of Monopolies is worth understanding carefully. It restricted the grant of patents to inventions that were new at the time of the grant, protected the rights of existing workers (the Crown could not use patents to put skilled tradespeople out of work), and capped the monopoly term at 14 years. In the roughly 200 years following the Statute, patent law was developed largely through judicial decisions in courts rather than through fresh legislation – lawyers and judges slowly refined what counted as a valid patent claim, including the critical requirement that a patent application include a written specification describing how the invention worked.

The political context behind the statute 🔗

It would be a mistake to view the Statute of Monopolies as purely a legal reform driven by ideals. Scholars have argued that the statute is best understood as a political compromise between the Crown, the House of Lords, and merchant interests, shaped by economic depression, succession pressures, and rivalry among trading centres like the City of London. It was opportunistic legislation as much as principled reform – yet its legal consequences endured for centuries regardless of its origins.

From royal grants to modern intellectual property 🔗

Towards the end of the 18th century, influenced by Enlightenment philosophy – particularly the ideas of John Locke – patents began to be conceptualised as intellectual property rights belonging naturally to inventors, rather than privileges gifted by the state. This philosophical reframing was fundamental. It shifted the justification for patent protection from “what the Crown allows” to “what the inventor deserves” – a basis that continues to underpin modern patent law.

Industrialisation also brought new challenges. The abuse of patent privilege to block competition became a recognised problem – the case of Boulton and Watt, who used their steam engine patents aggressively to prevent rivals from improving upon the technology, became a notorious example of how patent monopolies could suppress rather than promote innovation. This tension between incentivising inventors and ensuring public access has never fully disappeared; it shapes patent policy debates to this day.

The evolution of patent law in India 🔗

India’s patent history follows a distinct trajectory that cannot be separated from its colonial past and post-independence development priorities. India’s patent law reflects a shift from colonial dependency on British models to a uniquely Indian framework that prioritises access to medicines, public welfare, and industrial growth.

Colonial beginnings: 1856 to 1911 🔗

India’s first patent legislation was introduced in 1856 under British rule, modelled on English patent law. This was later replaced by the Indian Patents and Designs Act, 1911. However, under the 1911 Act, foreign corporations held nearly 80-90% of patents in India, yet only about 10% were actually worked locally – meaning Indian consumers were paying for goods protected by foreign patents, while domestic industry remained stunted and medicines remained expensive.

The Patents Act, 1970: India’s own framework 🔗

After independence, India recognised that its colonial-era patent law served foreign interests, not its own developmental goals. Based on the recommendations of the Ayyangar Committee Report (1959), India enacted the Patents Act, 1970, which came into force in 1972. This Act made a deliberate and consequential choice: it allowed only process patents in the pharmaceutical sector, not product patents. This meant Indian companies could manufacture the same drug using a different process, making essential medicines affordable for millions.

The 1970 Act specifically allowed process patents in pharmaceuticals, enabling Indian companies to produce generic versions of patented foreign drugs through different manufacturing processes without infringing intellectual property rights. The result was the growth of a robust domestic pharmaceutical industry – companies like Cipla and Dr. Reddy’s became global names, and India earned its reputation as the “pharmacy of the world.”

TRIPS compliance and the 2005 transformation 🔗

When India joined the World Trade Organization (WTO) on 1 January 1995, it also became a signatory to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). TRIPS required member nations to offer patent protection for both products and processes across all fields of technology, including pharmaceuticals – directly challenging the approach India had taken under the 1970 Act.

India navigated this through a staged approach: amendments in 1999, 2002, and finally the landmark Patent (Amendment) Act, 2005, which introduced product patents and repealed Section 5 (which had previously excluded pharmaceutical product patents). However, India did not simply surrender its public health concerns. Section 3(d) of the amended Act – which prevents “evergreening” of pharmaceutical patents by blocking minor modifications of known drugs from receiving fresh patent protection – became one of the most debated provisions in global IP law. It was upheld by the Supreme Court of India in the celebrated Novartis AG v. Union of India (2013) case, affirming that genuine innovation, not incremental tweaking, is the benchmark for patentability.

What unites this entire evolution? 🔗

From the English Crown’s arbitrary monopoly grants to Venice’s 1474 statute, from the Statute of Monopolies 1624 to India’s TRIPS-compliant Patents Act – the thread running through this entire history is a fundamental tension: how do you reward inventors without harming the public? Every major reform in patent law has been, at its core, an attempt to recalibrate this balance. The Statute of Monopolies checked royal excess. The 1970 Indian Act checked foreign corporate dominance. The 2005 Amendment checked the risk that TRIPS compliance would price out millions from essential medicines. Section 3(d) checks evergreening. Each intervention reflects the same underlying question, asked in a different era, with different stakes.

Today, patent law in India is administered by the Office of the Controller General of Patents, Designs and Trade Marks under the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry. The current framework grants patent protection for 20 years from the date of filing, subject to conditions of novelty, inventive step, and industrial applicability – a system that owes its conceptual DNA, directly or indirectly, to that pivotal statute passed by the English Parliament four centuries ago.

What do you think? Given that the Statute of Monopolies 1624 was as much a political compromise as a principled legal reform, does the origin of a law affect how we should evaluate its long-term legitimacy? And considering how India used the 1970 Patents Act to protect public health against foreign monopolies, do you think developing nations today have enough flexibility under the TRIPS framework to do the same?

References

1. https://www.ageofinvention.xyz/p/age-of-invention-the-statute-of-monopolies
2. https://en.wikipedia.org/wiki/History_of_patent_law
3. https://www.wilsongunn.com/history/history_patents.html
4. https://en.wikipedia.org/wiki/Statute_of_Monopolies
5. https://www.copyrighthistory.org/cam/tools/request/showRecord.php?id=commentary_uk_1624
6. https://digitalcommons.law.scu.edu/facpubs/77/
7. https://law.unimelb.edu.au/__data/assets/pdf_file/0003/1705278/33_2_4.pdf
8. https://www.ijllr.com/post/evolution-of-patent-law-in-india-historical-trajectory-amendments-and-contemporary-challenges
9. https://www.intellectbastion.com/comprehensive-analysis-of-the-patent-act-1970-legal-framework-strategic-evolution-in-india/
10. https://testbook.com/ias-preparation/indian-patent-act
11. https://www.rkdewan.com/blogs/patent-system-in-india/
12. https://link.springer.com/chapter/10.1007/978-981-13-8102-7_12
13. https://ipindia.gov.in